| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 30.696 | 0 | - | - | - | - | - | - | - | - |
| Total Income - EUR | 30.696 | 0 | - | - | - | - | - | - | - | - |
| Total Expenses - EUR | 1.924 | 11.553 | - | - | - | - | - | - | - | - |
| Gross Profit/Loss - EUR | 28.773 | -11.553 | - | - | - | - | - | - | - | - |
| Net Profit/Loss - EUR | 27.852 | -11.553 | - | - | - | - | - | - | - | - |
| Employees | 0 | 0 | - | - | - | - | - | - | - | - |
Check the financial reports for the company - Vital O2 Medinternational Srl-D
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 33.759 | 21.862 | - | - | - | - | - | - | - | - |
| Current Assets | 17.504 | 17.325 | - | - | - | - | - | - | - | - |
| Inventories | 0 | 0 | - | - | - | - | - | - | - | - |
| Receivables | 7.383 | 7.307 | - | - | - | - | - | - | - | - |
| Cash | 10.121 | 10.018 | - | - | - | - | - | - | - | - |
| Shareholders Funds | 43.543 | 31.546 | - | - | - | - | - | - | - | - |
| Social Capital | 45 | 45 | - | - | - | - | - | - | - | - |
| Debts | -2.364 | 7.641 | - | - | - | - | - | - | - | - |
| Income in Advance | 10.083 | 9.981 | - | - | - | - | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Vital O2 Medinternational Srl-D